Cardiology

Top Story

Menopause may play role in CVD risk in older women

Menopause may play role in CVD risk in older women
June 23, 2018
FDA News

Petition calls for FDA to remove febuxostat from market due to CV mortality risk

June 22, 2018
Public Citizen, a nonprofit consumer advocacy organization, has petitioned the FDA to remove the gout medication febuxostat due to what it calls “unique, serious…
FDA News

FDA permits marketing of first catheter-based systems for vascular access for patients on hemodialysis

June 22, 2018
The FDA has granted marketing authorization for the use of the Ellipsys Vascular Access System and the everlinQ endoAVF System to make percutaneous arteriovenous…
Meeting News

Statin therapy reduces mortality risk after revascularization in CLI

June 22, 2018
Patients who received moderate- or high-intensity statin therapy 1 year after revascularization for chronic limb-threatening ischemia were more likely to survive long…
In the Journals

Switch from ticagrelor to clopidogrel increases platelet reactivity

June 22, 2018
A de-escalation that consisted of a switch from ticagrelor to clopidogrel therapy conferred an increase in platelet reactivity, researchers reported in Circulation. For…
More Headlines »
CME

Elevated CV Risk in Patients with Diabetes: Causes, Implications, and New Management Strategies

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Cardiovascular disease (CVD) is the leading cause of death in the United States for both men and women, claiming
More »
Video
In the Journals

VIDEO: Experts discuss challenging aspects of endovascular therapy

June 17, 2018
More »
Resource Centers
Heart Rhythm Society Scientific Sessions

Heart Rhythm Society Scientific Sessions

Video
Meeting News

VIDEO: Experts discuss stimulating areas of vascular intervention

June 13, 2018
More »